The role of the Hippo pathway in autophagy in the heart
Cardiovascular Research · 18.01.2023 · 118 (17) · 3320-3330
DOI: 10.1093/cvr/cvac014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 12.02.2022. Verfasst von Yasuhiro Maejima und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, 185 South Orange Ave., MSB G…. Hauptthemen laut MEDLINE: Hippo Signaling Pathway, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Public Health Service Grants, U.S. Public Health Service, American Heart Association.
Abstract (Originalsprache)
The Hippo pathway, an evolutionarily conserved signalling mechanism, controls organ size and tumourigenesis. Increasing lines of evidence suggest that autophagy, an important mechanism of lysosome-mediated cellular degradation, is regulated by the Hippo pathway, which thereby profoundly affects cell growth and death responses in various cell types. In the heart, Mst1, an upstream component of the Hippo pathway, not only induces apoptosis but also inhibits autophagy through phosphorylation of Beclin 1. YAP/TAZ, transcription factor co-factors and the terminal effectors of the Hippo pathway, affect autophagy through transcriptional activation of TFEB, a master regulator of autophagy and lysosomal biogenesis. The cellular abundance of YAP is negatively regulated by autophagy and suppression of autophagy induces accumulation of YAP, which, in turn, acts as a feedback mechanism to induce autophagosome formation. Thus, the Hippo pathway and autophagy regulate each other, thereby profoundly affecting cardiomyocyte survival and death. This review discusses the interaction between the Hippo pathway and autophagy and its functional significance during stress conditions in the heart and the cardiomyocytes therein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, 185 South Orange Ave., MSB G-609, Newark, NJ 07103, USA.
- Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
- School of Biological Sciences, Seoul National University, Seoul 08826, Korea.
ORCID-Profile: Jihoon Nah, Junichi Sadoshima
Förderung
- U.S. Public Health Service Grants
- U.S. Public Health Service
- American Heart Association
- Fondation Leducq Transatlantic Network of Excellence
- NIH
Zitieren
APA
Maejima, Y., Zablocki, D., Nah, J., & Sadoshima, J. (2023). The role of the Hippo pathway in autophagy in the heart. Cardiovascular Research, 118(17), 3320-3330. https://doi.org/10.1093/cvr/cvac014
Vancouver
Maejima Y, Zablocki D, Nah J, Sadoshima J. The role of the Hippo pathway in autophagy in the heart. Cardiovascular Research. 2023;118(17):3320-3330. doi:10.1093/cvr/cvac014
BibTeX
@article{Maejima2023,
author = {Maejima, Yasuhiro and Zablocki, Daniela and Nah, Jihoon and Sadoshima, Junichi},
title = {The role of the Hippo pathway in autophagy in the heart},
journal = {Cardiovascular Research},
year = {2023},
volume = {118},
number = {17},
pages = {3320--3330},
doi = {10.1093/cvr/cvac014}
}
EUVIMED